ABCG2 and cancer: Multiple studies indicated that the exposure of cancer cells to HDAC inhibitors could induce the activation of several drug resistance‐associated ABC transporters, which in turn lead to a broad‐spectrum of drug resistance effect in the treatment of cancer.34